Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 1125

1.

Modulatory effects of inflammation and therapy on GDF-5 expression in rheumatoid arthritis synovium.

Bramlage CP, Kaps C, Ungethüm U, Bramlage P, Koziolek M, Wessels J, Krenn V, Pruss A, Müller GA, Strutz F, Burmester GR, Häupl T.

Scand J Rheumatol. 2008 Nov-Dec;37(6):401-9. doi: 10.1080/03009740802120010.

PMID:
18830904
2.

GDF-5 is suppressed by IL-1beta and enhances TGF-beta3-mediated chondrogenic differentiation in human rheumatoid fibroblast-like synoviocytes.

Liu FL, Lin LH, Sytwu HK, Chang DM.

Exp Mol Pathol. 2010 Feb;88(1):163-70. doi: 10.1016/j.yexmp.2009.09.019. Epub 2009 Oct 8.

PMID:
19818765
3.

Responses to the proinflammatory cytokines interleukin-1 and tumor necrosis factor alpha in cells derived from rheumatoid synovium and other joint tissues involve nuclear factor kappaB-mediated induction of the Ets transcription factor ESE-1.

Grall F, Gu X, Tan L, Cho JY, Inan MS, Pettit AR, Thamrongsak U, Choy BK, Manning C, Akbarali Y, Zerbini L, Rudders S, Goldring SR, Gravallese EM, Oettgen P, Goldring MB, Libermann TA.

Arthritis Rheum. 2003 May;48(5):1249-60.

4.

Comparison of cathepsins K and S expression within the rheumatoid and osteoarthritic synovium.

Hou WS, Li W, Keyszer G, Weber E, Levy R, Klein MJ, Gravallese EM, Goldring SR, Brömme D.

Arthritis Rheum. 2002 Mar;46(3):663-74.

5.

Transforming growth factor beta 1(TGF-beta1) down-regulates TNFalpha-induced RANTES production in rheumatoid synovial fibroblasts through NF-kappaB-mediated transcriptional repression.

Cho ML, Min SY, Chang SH, Kim KW, Heo SB, Lee SH, Park SH, Cho CS, Kim HY.

Immunol Lett. 2006 Jun 15;105(2):159-66. Epub 2006 Mar 3.

PMID:
16564576
6.

Kinesin-like protein CENP-E is upregulated in rheumatoid synovial fibroblasts.

Kullmann F, Judex M, Ballhorn W, Jüsten HP, Wessinghage D, Welsh J, Yen TJ, Lang B, Hittle JC, McClelland M, Gay S, Schölmerich J, Müller-Ladner U.

Arthritis Res. 1999;1(1):71-80. Epub 1999 Oct 26.

7.

Reduction of synovial sublining layer inflammation and proinflammatory cytokine expression in psoriatic arthritis treated with methotrexate.

Kane D, Gogarty M, O'leary J, Silva I, Bermingham N, Bresnihan B, Fitzgerald O.

Arthritis Rheum. 2004 Oct;50(10):3286-95.

8.

Overexpression of transcription factor Ets-1 in rheumatoid arthritis synovial membrane: regulation of expression and activation by interleukin-1 and tumor necrosis factor alpha.

Redlich K, Kiener HP, Schett G, Tohidast-Akrad M, Selzer E, Radda I, Stummvoll GH, Steiner CW, Gröger M, Bitzan P, Zenz P, Smolen JS, Steiner G.

Arthritis Rheum. 2001 Feb;44(2):266-74.

9.

Tumor necrosis factor alpha promotes the expression of stem cell factor in synovial fibroblasts and their capacity to induce mast cell chemotaxis.

Kiener HP, Hofbauer R, Tohidast-Akrad M, Walchshofer S, Redlich K, Bitzan P, Kapiotis S, Steiner G, Smolen JS, Valent P.

Arthritis Rheum. 2000 Jan;43(1):164-74.

10.

Constitutive upregulation of the transforming growth factor-beta pathway in rheumatoid arthritis synovial fibroblasts.

Pohlers D, Beyer A, Koczan D, Wilhelm T, Thiesen HJ, Kinne RW.

Arthritis Res Ther. 2007;9(3):R59.

11.

Wnt1 inducible signaling pathway protein-3 regulation and microsatellite structure in arthritis.

Cheon H, Boyle DL, Firestein GS.

J Rheumatol. 2004 Nov;31(11):2106-14.

PMID:
15517620
12.

Interleukin 16 expression in relation to disease activity in rheumatoid arthritis.

Blaschke S, Schulz H, Schwarz G, Blaschke V, Müller GA, Reuss-Borst M.

J Rheumatol. 2001 Jan;28(1):12-21.

PMID:
11196512
13.

Expression of ADAM15 in rheumatoid synovium: up-regulation by vascular endothelial growth factor and possible implications for angiogenesis.

Komiya K, Enomoto H, Inoki I, Okazaki S, Fujita Y, Ikeda E, Ohuchi E, Matsumoto H, Toyama Y, Okada Y.

Arthritis Res Ther. 2005;7(6):R1158-73. Epub 2005 Aug 5.

14.

Antirheumatic drug response signatures in human chondrocytes: potential molecular targets to stimulate cartilage regeneration.

Andreas K, Häupl T, Lübke C, Ringe J, Morawietz L, Wachtel A, Sittinger M, Kaps C.

Arthritis Res Ther. 2009;11(1):R15. doi: 10.1186/ar2605. Epub 2009 Feb 3.

15.

Tumor necrosis factor-alpha promotes the expression of osteoprotegerin in rheumatoid synovial fibroblasts.

Kubota A, Hasegawa K, Suguro T, Koshihara Y.

J Rheumatol. 2004 Mar;31(3):426-35.

PMID:
14994384
16.

Macrophage migration inhibitory factor in rheumatoid arthritis: evidence of proinflammatory function and regulation by glucocorticoids.

Leech M, Metz C, Hall P, Hutchinson P, Gianis K, Smith M, Weedon H, Holdsworth SR, Bucala R, Morand EF.

Arthritis Rheum. 1999 Aug;42(8):1601-8.

17.

Systemic TNF blockade does not modulate synovial expression of the pro-inflammatory mediator HMGB1 in rheumatoid arthritis patients--a prospective clinical study.

Sundberg E, Grundtman C, Af Klint E, Lindberg J, Ernestam S, Ulfgren AK, Harris HE, Andersson U.

Arthritis Res Ther. 2008;10(2):R33. doi: 10.1186/ar2387. Epub 2008 Mar 17.

18.
19.

Constitutive expression of angiopoietin-1 and -2 and modulation of their expression by inflammatory cytokines in rheumatoid arthritis synovial fibroblasts.

Scott BB, Zaratin PF, Colombo A, Hansbury MJ, Winkler JD, Jackson JR.

J Rheumatol. 2002 Feb;29(2):230-9.

PMID:
11838839
20.

Expression of the precursor of secretoneurin, secretogranin II, in the synovium of patients with rheumatoid arthritis and osteoarthritis.

Sprott H, Pap T, Rethage J, Wintersberger W, Gay RE, Bradley LA, Uebelhart D, Gay S.

J Rheumatol. 2000 Oct;27(10):2347-50.

PMID:
11036828

Supplemental Content

Support Center